NASDAQ:IMRX - US45254E1073 - Common Stock
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net Income | -61.77M | -61.04M | -53.47M | -50.51M | -33.54M | |||
Depreciation Amortization | 380.40K | 385.10K | 352.10K | 280.00K | 50.00K | |||
Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | -310.00K | |||
Change In Working Capital | 852.10K | -925.40K | -974.60K | 1.72M | 900.00K | |||
Other non cash items | 6.95M | 6.58M | 5.13M | 4.42M | 2.05M | |||
OPERATING CASH FLOW | -54.08M | -55.00M | -48.97M | -44.10M | -30.85M | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital Expenditure | -53.90K | -84.90K | -342.80K | -740.00K | -60.00K | |||
Other Investing Activity | 5.52M | 26.52M | 7.64M | 42.57M | -75.56M | |||
INVESTING CASH FLOW | 5.43M | 26.43M | 7.30M | 41.83M | -75.62M | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
Stock Issued/Repurchased | 18.18M | 5.34M | 28.64M | 300.00K | 146.39M | |||
Other Financing Activity | N/A | -41.00K | -203.80K | -280.00K | -2.12M | |||
FINANCING CASH FLOW | 18.13M | 5.30M | 28.44M | 20.00K | 144.26M | |||
CHANGE IN CASH | -30.52M | -23.26M | -13.23M | -2.25M | 37.79M | |||
FREE CASH FLOW | ||||||||
Operating Cash Flow | -54.08M | -55.00M | -48.97M | -44.10M | -30.85M | |||
Capital Expenditure | -53.90K | -84.90K | -342.80K | -740.00K | -60.00K | |||
FREE CASH FLOW | -54.13M | -55.08M | -49.31M | -44.84M | -30.91M |
All data in USD